Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003

Emerging Infectious Diseases

Volumn 11, Issue 6, 2005, Pages 939-942

  Malhotra Kumar, Surbhi ^a   Lammens, Christine ^a   Chapelle, Sabine ^a   Wijdooghe, Monique ^a   Piessens, Jasper ^a   Van Herck, Koen ^a   Goossens, Herman ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; TELITHROMYCIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BELGIUM; CHILD; CLONAL VARIATION; CONTROLLED STUDY; GENE TRANSFER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PHARMACOGENETICS; PHARYNGITIS; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; STREPTOCOCCUS PYOGENES;

EID: 19344374419     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1106.041247     Document Type: Article

References (19)

1. Descheemaeker P, Chapelle S, Lammens C, Hauchecorne M, Wijdooghe M, Vandamme P, et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother. 2000;45:167-73.
2. Canton R, Loza E, Morosini MI, Baquero F. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000. J Antimicrob Chemother. 2002;50(Suppl S1):9-24.
3. Cornaglia G, Ligozzi M, Mazzariol A, Masala L, Lo CG, Orefici G, et al. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance. Clin Infect Dis. 1998;27(Suppl 1):S87-S92.
4. Szczypa K, Sadowy E, Izdebski R, Hryniewicz W. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J Antimicrob Chemother. 2004;54:828-31.
5. Iannelli F, Santagati M, Docquier JD, Cassone M, Oggioni MR, Rossolini G, et al. Type M resistance to macrolides in streptococci is not due to the mef(A) gene, but to mat(A) encoding an ATP-dependent efflux pump [Abstract C1-1188]. Presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Washington; 2004 Oct 30-Nov 2.
6. Reinert RR, Lutticken R, Sutcliffe JA, Tait-Kamradt A, Cil MY, Schorn HM, et al. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrob Agents Chemother. 2004;48:1369-73.
7. NCCLS. National Committee for Clinical laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement, M100-S12. Wayne (PA); The Committee; 2002.
8. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
9. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother. 1996;40:2562-6.
10. Malhotra-Kumar S, Wang S, Lammens C, Chapelle S, Goossens H. Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium. J Clin Microbiol. 2003;41:5282-4.
11. Malbruny B, Nagai K, Coquemont M, Bozdogan B, Andrasevic AT, Hupkova H, et al. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother. 2002;49:935-9.
12. Novotny GW, Jakobsen L, Andersen NM, Poehlsgaard J, Douthwaite S. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA. Antimicrob Agents Chemother. 2004;48:3677-83.
13. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Martin JE. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol. 2002;40:2959-63.
14. Bergman M, Huikko S, Pihlajamaki M, Laippala P, Palva E, Huovinen P, et al. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis. 2004;38:1251-6.
15. Granizo JJ, Aguilar L, Casal J, Dal Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother. 2000;46:959-64.
16. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance. Lancet. 2005;365:579-87.
17. Weber P, Filipecki J, Bingen E, Fitoussi F, Goldfarb G, Chauvin JP, et al. Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemother. 2001;48:291-4.
18. Kaplan EL, Wotton JT, Johnson DR. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis. Lancet. 2001;358:1334-7.
19. Nielsen HU, Hammerum AM, Ekelund K, Bang D, Pallesen LV, Frimodt-Moller N. Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb Drug Resist. 2004;10:231-8.